Adaptive Biotechnologies ...

NASDAQ: ADPT · Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.04
0.08%
After-hours: Aug 15, 2025, 04:54 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-159.59M -225.25M -200.37M -207.3M
Depreciation & Amortization
19.26M 22.23M 20.92M 13.95M
Stock-Based Compensation
53.61M 62.91M 55.48M 43.25M
Other Working Capital
-16.32M -44.2M -56.83M -49.48M
Other Non-Cash Items
8.97M 29.97M 11.57M 6.95M
Deferred Income Tax
n/a n/a n/a 7.23M
Change in Working Capital
-17.45M -46.18M -71.55M -56.82M
Operating Cash Flow
-95.21M -156.32M -183.94M -192.73M
Capital Expenditures
-3.66M -10.7M -16.35M -61.75M
Cash Acquisitions
n/a n/a -19.25M -181.21M
Purchase of Investments
-244.26M -429.56M -278.78M -316.54M
Sales Maturities Of Investments
325.71M 569.9M 298.03M 559.5M
Other Investing Acitivies
n/a n/a 19.25M 181.21M
Investing Cash Flow
77.79M 129.65M 2.9M 181.21M
Debt Repayment
n/a n/a 124.38M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
241K 2.25M 7.89M 27.15M
Financial Cash Flow
241K 2.25M 132.26M 27.15M
Net Cash Flow
-17.18M -24.43M -48.77M 15.63M
Free Cash Flow
-98.88M -167.02M -200.29M -254.47M